Skip to content

Ardelyx ARDX Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net

Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net at other companies

Amgen logo
AmgenAMGN
Bausch Health Companies logo
Bausch Health CompaniesBHC

Other financials

Income statement

See full
Revenue$94.5M+27.5%
Gross profit$89.7M+45.1%
Operating income-$32.8M+9.8%
Net income-$37.6M+8.6%
EPS (diluted)-$0.15+11.8%

Balance sheet

See full
Cash & equivalents$31.2M+1.3%
Total debt$208.3M+34.3%
Total equity$148.6M+2.0%
Total assets$504.5M+23.0%

Cash flow

See full
Operating cash flow-$32.2M+16.2%
CapEx$69.0K-78.8%
Free cash flow-$32.3M+16.7%

Valuation

See full
Market cap$1.53B+79.5%
Enterprise value$1.71B+74.8%
P/S3.6×+1.2×

Profitability

See full
Gross margin92.5%+7.9pp
Operating margin-25.4%
Net margin-13.6%
FCF margin-40.9%

Returns & leverage

See full
Return on equity-39.5%
Debt / equity1.4×+0.3×
Current ratio3.5×-0.6×

Where this comes from

Reported directly by Ardelyx in its filing.

Tagged under the XBRL concept us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet.

The official record: Ardelyx’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ardelyx's debt instrument, unamortized discount (premium) and debt issuance costs, net.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ardelyx's debt instrument, unamortized discount (premium) and debt issuance costs, net?
Ardelyx (ARDX) reported debt instrument, unamortized discount (premium) and debt issuance costs, net of $1.03M in Q1 2026.
How has Ardelyx's debt instrument, unamortized discount (premium) and debt issuance costs, net changed year-over-year?
Ardelyx's debt instrument, unamortized discount (premium) and debt issuance costs, net decreased by 3.8% year-over-year, from $1.07M to $1.03M.
What is the long-term trend for Ardelyx's debt instrument, unamortized discount (premium) and debt issuance costs, net?
Over 4 years (2021 to 2025), Ardelyx's debt instrument, unamortized discount (premium) and debt issuance costs, net has grown at a 48.0% compound annual growth rate (CAGR), from $235K to $1.13M.